## Interpretation of HBV Serology: Low Replicative Phase ### Serological Profile Analysis | Marker | Result | Interpretation | | --- | --- | --- | | **HBsAg** | Positive | Chronic HBV infection (persists >6 months) | | **Anti-HBc** | Positive | Evidence of past or ongoing HBV exposure | | **HBeAg** | Negative | Low/absent viral replication | | **Anti-HBe** | Positive | Seroconversion from HBeAg (replicative phase ended) | **Key Point:** The combination of **HBsAg+ / HBeAg− / Anti-HBe+** defines the **low replicative phase** of chronic hepatitis B, also called the **HBeAg-negative carrier state** or **low-infectivity chronic infection**. ### Clinical Significance **High-Yield:** This profile indicates: - Chronic HBV infection (HBsAg persistence ≥6 months) - **Low viral load** and **low infectivity** compared to HBeAg-positive patients - Possible prior HBeAg seroconversion (transition from high to low replication) - Lower risk of transmission but still infectious **Clinical Pearl:** Patients in this phase may have: - Normal or mildly elevated transaminases - Slower progression to cirrhosis (but still at risk) - Better prognosis than HBeAg-positive chronic infection - Possible flares if HBeAg reappears ### Why Not the Other Options? 1. **Acute infection** — would show **anti-HBc IgM**, not IgG; HBeAg would typically be positive with high infectivity 2. **Resolved infection** — would show **anti-HBs** (not HBsAg); HBsAg would be negative 3. **Vaccination** — would show **only anti-HBs**; HBsAg and anti-HBc would both be negative [cite:Harrison 21e Ch 298]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.